Rocky Mountain Cancer Centre, LLP is a clinical research site located in Lone Tree, Colorado, United States 80124.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Rocky Mountain Cancer Centre, LLP has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: HER2-positive Breast Cancer.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rocky Mountain Cancer Centre, LLP has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rocky Mountain Cancer Centre, LLP has 1 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer.
Rocky Mountain Cancer Centre, LLP has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.